Stepwise Embryonic Stem Cell Differentiation into Single-Hormone Beta Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for differentiating human embryonic stem cells into functional pancreatic beta cells have fallen short of producing cells with characteristics of mature beta cells, including single hormonal insulin production, correct processing of proinsulin, and appropriate insulin release in response to glucose, often resulting in polyhormonal cells that do not function effectively.
Innovation Solution
A stepwise differentiation method using defined conditions, including the precise timing of BMP inhibition and the use of retinoic acid gradients along with Vitamin C, to cultivate human embryonic stem cells into pancreatic beta cells, ensuring greater than 10% of the population expresses markers characteristic of single hormonal insulin production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional differentiation methods are used, then stem cells can be differentiated into pancreatic beta cells, but the cells produced are polyhormonal and do not function effectively
Solution Approach 1:
The differentiation process is divided into multiple discrete stages (definitive endoderm formation, foregut endoderm specification, pancreatic endoderm differentiation, and beta cell maturation). Each stage uses specific signaling molecules and conditions to guide cells through precise developmental transitions, ensuring single-hormone insulin production rather than polyhormonal output.
Solution Approach 2:
The protocol employs dynamic adjustment of culture conditions including temporal control of BMP inhibition, retinoic acid gradient application, and Vitamin C supplementation. These parameter changes drive the cells through specific differentiation pathways that produce functionally mature, single-hormonal insulin-positive cells.
2Manufacturing precision
If stepwise differentiation with defined conditions is applied, then single hormonal insulin positive cells can be produced, but the process complexity increases
Solution Approach 1:
The protocol establishes definitive endoderm and foregut endoderm stages before reaching pancreatic endoderm differentiation. This preliminary action ensures that cells are properly primed with appropriate transcription factors and signaling pathways activated before the critical beta cell differentiation step, simplifying the overall process control.
Solution Approach 2:
The differentiation protocol uses intermediary substances such as retinoic acid gradients and Vitamin C as mediators between culture stages. These intermediaries facilitate smooth transitions between differentiation phases and help maintain cell identity, reducing the need for complex multi-factor control systems.
3Quantity of substance
If conventional differentiation protocols are used, then beta cell production is achieved, but insulin processing and release functionality is insufficient
Solution Approach 1:
The protocol maintains continuous glucose supplementation throughout the differentiation process and includes sustained retinoic acid gradient application. This continuous action ensures that insulin processing enzymes and glucose-responsive release mechanisms are continuously developed and refined, producing functionally mature cells capable of appropriate insulin secretion.
Data Source
AI summary
The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides methods to produce a population of cells, wherein greater than 10% of the cells in the population express markers characteristic of single hormonal pancreatic beta cells.